| ||
| Cancer Trials Matching Medicines to Mutations Increase Odds of Success Bloomberg "Fortunately, my colleagues in commercial development immediately recognized that, given the high incidence of non- small-cell lung cancer, it still accounted for a considerable number of patients," Rothenberg said. Matching tumors to treatment isn'ta ... See all stories on this topic » | ||
| Celgene and Acceleron commence new cancer drug trial Zenopa The companies are beginning the first part of a phase II/III study of ACE-011 for treating chemotherapy-induced anaemia in patients with metastatic non-small cell lung cancer. It will begin with a dose-ranging study for the treatment, before leading ... See all stories on this topic » | ||
| Methylgene Discloses Encouraging Safety And Efficacy Data Of MGCD265 RTT News Out of the 24, eight were non-small cell lung cancer or NSCLC patients. Six patients were on study for more than four cycles with two experiencing partial responses and three experiencing prolonged disease stabilization. In 34 patients, MGCD265 was ... See all stories on this topic » | ||
| Investment in Oncology Drug Development Remains Strong as 133 Companies ... Review seeker (press release) Trials targeting non-small cell lung cancer, breast cancer and multiple hematological cancers are amongst the most active, while Roche and Novartis had the most oncology trial starts of any company By PR Newswire NEW YORK, June 2, 2011 /PRNewswire/ ... See all stories on this topic » | ||
| Bridging gender gap in science The Almanac Online Another speaker, Dr. Jill Helms, is a craniofacial surgeon and stem cell researcher at Stanford. She chose to go into medicine after her mother developed lung cancer. "That was a real turning point," she said. "I wanted to make a difference. ... See all stories on this topic » | ||
| Former N.H. Gov. Walter Peterson dies of lung cancer Seacoastonline.com The Republican Gov., who was the state's chief executive for four years in the late 1960s and early 1970s, has died of lung cancer.AP photo By Holly Ramer Associated Press CONCORD — Former New Hampshire Gov. Walter Peterson who was the state's chief ... See all stories on this topic » |
| ||
| Optimized delivery method enhances SBRT - MedicalPhysicsWeb Stereotactic body radiotherapy (SBRT) is a common treatment option for patients presenting with medically inoperable, peripheral, early stage non-small cell lung cancer (NSCLC) – by virtue of its ability to minimize the dose received by ... medicalphysicsweb: Research &... - http://medicalphysicsweb.org/cws/channel/research | ||
| Roche's Tarceva helps lung cancer patients -Lung Cancer news- Roche, the world's largest maker of cancer drugs, said the data showed Tarceva nearly doubled the median progression-free survival of Western patients with a genetically distinct type of advanced non-small cell lung cancer, ... Cancer: Overview, Causes, Risk... - http://www.health.am/cr/ | ||
| Investment in oncology drug development remains strong, with 133 ... Trials targeting non-small cell lung cancer, breast cancer and multiple hematological cancers are amongst the most active, while Roche and Novartis had the most oncology trial starts of any company, according to a new study. ... thepharmaletter.com - http://www.thepharmaletter.com/ | ||
| Clovis Oncology Receives License for Worldwide Development and ... By Erica Teichert Therefore, inhibition of PARP can prevent the repair of single strand DNA breaks , which in turn causes double strand DNA breaks and ultimately leads to cancer cell death. Additionally, PARP inhibitors may be particularly effective in treating ... cancer and CO-1686, an epidermal growth factor receptor (EGFR) mutant-selective inhibitor (EMSI) which is currently in pre-clinical development for non-small cell lung cancer (NSCLC) patients who express the T790M mutation. ... Press Releases - http://www.fiercebiotech.com/press-releases |
| ||
| Non-small cell lung cancer Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small-cell lung carcinoma (SCLC). As a class, NSCLCs are relatively ... www.medical-answers.org/hd/index.php?t=Non-small... | ||
| Two Novel Determinants of Etoposide Resistance in Small Cell Lung ... Patient survival in small cell lung cancer (SCLC) is limited by acquired chemoresistance. Here we report the use of a biologically relevant model to ... cancerres.aacrjournals.org/.../0008-5472.CAN-11-0080.abstra... | ||
| Non-Small Cell Lung Cancer Clinical Trial: Study Evaluating the ... This is a Phase II, multicenter, randomized, double-blind, placebo-controlled trial designed to evaluate the efficacy and safety of MEGF0444A combined with ... clinicaltrialsfeeds.org/clinical-trials/show/NCT01366131 | ||
| Results of three Phase II Trials in Lung Cancer Indications ... Initial analysis of a randomised Phase II trial in non-small cell lung cancer, along with top line results of a Phase II trial in small-cell lung cancer and ... www.live-pr.com/.../results-of-three-phase-ii-trials-r10489270... | ||
| NSCLC – Non Small Cell Lung Cancer Lucanix Vaccine Expanded Access www.ircofca.com 1-877-680-IRCC (4722) Innovative Research Center of California ( IRCC) is an independent, dedicated research facility that specializes in ... canceroflung.org/nsclc-non-small-cell-lung-cancer.../.php |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment